key: cord-0848864-unq8ekhi authors: Cherif, Mohamed Aziz; Loganadane, Gokoulakrichenane; Debbi, Kamel; Coraggio, Gabriele; Ghith, Sahar; Hadhri, Asma; Hassani, Wissal; Grellier, Noémie; To, Nhu Hanh; Belkacemi, Yazid title: Radiotherapy delivery challenges in elderly patients during Coronavirus 19 (Covid-19) pandemic date: 2020-12-05 journal: Adv Radiat Oncol DOI: 10.1016/j.adro.2020.11.011 sha: b38201353bc5ba631bfe865c931cf3b16b7bb1de doc_id: 848864 cord_uid: unq8ekhi PURPOSE: The management of elderly patients in radiotherapy (RT) departments has been challenging in the context of the Coronavirus 19 (Covid-19) outbreak. We report our experience of RT adapted schedules or strategy changes in older patients during the Covid-19 pandemic. METHODS AND MATERIALS: Patients aged ≥75 years were recruited during weekly chart rounds. All were potentially eligible for a specific intervention to reduce the frequency of patients’ visits to the hospital. The impact of deferring radiation and hypofractionation of RT schedules was assessed in terms of the number of courses initially planned and re-planned during the lockdown. RESULTS: Twenty patients were identified during the official lockdown in France (March 17 to May 11). Median age was 78y (75-95y). Most patients were male (n=12, 60%) being treated in the postoperative setting (n=17, 85%). RT was delayed in 11 cases (55%) with hormonal therapy prescribed in 10 cases (50%). Altered RT fractionation was proposed for five cases (25%) combinations of altered fractionation and deferral of radiation were applied in three cases (15%). The number of radiation courses initially planned and re-planned according to the pandemic context: 563 and 197 respectively (-62%; p<0.001). None presented recurrence when RT was initiated, and no patient developed symptomatic Covid-19 infection. CONCLUSIONS: In the context of the Covid-19 outbreak, individual risk-based radiation therapy seems to be safe. Systematic screening of patients for Covid-19 before starting radiotherapy is mandatory. In our department the oncogeriatrics expertise availability for daily practice was of great use during the pandemic. Other prospective studies are needed to validate such strategies in case of resurgence of similar outbreaks. Patients aged ≥75 years were recruited during weekly chart rounds. All were potentially 7 eligible for a specific intervention to reduce the frequency of patients' visits to the hospital. 8 The impact of deferring radiation and hypofractionation of RT schedules was assessed in 9 terms of the number of courses initially planned and re-planned during the lockdown. 10 Twenty patients were identified during the official lockdown in France (March 17 to May 11). 12 Median age was 78y (75-95y). Most patients were male (n=12, 60%) being treated in the 13 postoperative setting (n=17, 85%). RT was delayed in 11 cases (55%) with hormonal therapy 14 prescribed in 10 cases (50%). Altered RT fractionation was proposed for five cases (25%) 15 combinations of altered fractionation and deferral of radiation were applied in three cases 16 (15%). The number of radiation courses initially planned and re-planned according to the 17 pandemic context: 563 and 197 respectively (-62%; p<0.001). None presented recurrence 18 when RT was initiated, and no patient developed symptomatic Covid-19 infection. 19 In the context of the Covid-19 outbreak, individual risk-based radiation therapy seems to be 21 safe. Systematic screening of patients for Covid-19 before starting radiotherapy is mandatory. 22 In our department the oncogeriatrics expertise availability for daily practice was of great use The first cases of human infection from Covid-19 were reported from 3 Wuhan, China in December 2019. Since then, the virus rapidly spread throughout the entire 4 world, especially in Europe which became the most affected continent within a few weeks. 5 Covid-19 is associated with high contagiousness related to respiratory droplets that can persist 6 on all surfaces for three hours and up to days (1) . Early data from China suggest that elderly 7 (2) patients with cancer (3) are disproportionately affected by Covid-19, from severe illness 8 and hospitalization to an increased rate of mortality. As acknowledged by various health 9 authorities, the optimal management of these patients was particularly challenging during the 10 early stages of the outbreak. In addition, general guidelines were released by the High Council 11 for Public health for the general population (4). More specifically for elderly patients, 12 geriatric societies emphasized the need to follow and to reinforce these guidelines for elderly 13 patients. Thus, the publication of national (5) and international guidelines for patients' care 14 from the IGRG (International Geriatric Radiotherapy Group) (6) and the International Society 15 of Geriatric Oncology (SIOG) (8) was of great help in decision-making. However, while some 16 were published late, after the extent of the pandemic in many countries, their application in 17 radiotherapy (RT) departments reduced the risk of contamination and allowed a better patient 18 selection for therapy. 19 The aim of this study was to assess the ratio of therapeutic effectiveness of radiation/risk of 20 infectious contamination for elderly patients. However, feedback and sharing of experience 21 for elderly patients during the pandemic in RT departments is lacking. Here we report our 22 experience with elderly patients referred to our department during the lockdown. We will 23 describe a personalized care plan (9) following the guidelines from the international early 24 recommandations for departments organization and cancer management during COVID-19 pandemic (10) in the context of the outbreak, taking into account various aspects of geriatric 1 frailty. 2 3 Department organization and preventive actions 5 In the early weeks of the Covid-19 outbreak, a general overhaul of our radiation oncology 6 department was implemented during the lockdown in order to protect our patients and our 7 staff. Regarding the safety recommendations for the medical staff (physicians, physicists and 8 therapists), there was implementation of information sessions, individual preventive actions 9 (hand washing, wearing of masks), collective preventive actions (social distancing, staff 10 turnover) and psychological assistance. Apart from reassessing indications for radiation and 11 postponing whenever possible, strong protective measures were applied for patients: reduced 12 number of visits to the clinic (hypofractionation, telemedicine), individual preventive actions 13 (hand washing, wearing of masks), and collective preventive actions: social distancing, 14 screening by front desk staff upon check-in, sanitization (waiting room, devices, treatment 15 couch) and individual transportation. The organizational procedures implemented in the early 16 stages of the Covid-19 pandemic in our department were previously reported (9). 17 In elderly patients, the decision to defer radiation therapy or the use of hypofractionation 18 schedules was taken in weekly chart rounds in presence of a radiation oncologists specialized 19 in geriatrics taking into account comorbidities and frailty of the individual. 20 Twenty patients were identified during the official lockdown in France from our weekly chart 22 rounds. All patients were potentially eligible for a specific intervention (deferral of radiation 23 or modification of fractionation) that allowed reduction in the number of visits and potential 24 exposure to Covid-19 during the lockdown. Age, gender and the Rockwood clinical frailty 1 score were assessed prospectively in all patients. 2 Analyses 3 The impact of deferring radiation and hypofractionation was assessed in terms of number of 4 courses initially planned and replanned during the lockdown. Pair-wise comparisons between 5 the number of radiation courses initially planned from March 17 to May 11and replanned 6 according to the Covid-19 outbreak were performed using two-tailed paired Student's t-test. 7 Statistical analyses were performed using the R software, Version 3.5.1 (R project, Vienna, 8 Austria). 9 Patients and co-morbidities 12 The median age of the cohort was 78 (75-95) years. The majority were men (n=12, 60%) and 13 were treated in the postoperative setting (n=17, 85%).Only three patients were free of 14 comorbidity. Thirteen (65%)patients had at least one cardiovascular risk factor. Seven patients 15 (35%) had no frailties while 7 (35%), 4 (20%) and 2 (10%) patients were considered fragile 16 because of their polymedication, autonomy loss and hearing impairment, respectively (Tables 17 1, 2). The Rockwood score was ≥4 in 14 patients (70%) (vulnerable to moderately frail) while 18 6 patients (30%) were fit ( Table 1 ). All were treated as outpatients. 19 Primary disease was prostate (n=9, 45%), breast (n=7, 35%), cutaneous squamous cell 21 carcinoma (n=3, 15%) and sarcoma (n=1, 5%). 22 Radiation therapy was deferred in 11 cases (55%). During this delay, primary hormonal 24 therapy was prescribed as a "waiting therapy" in 10 cases (9 prostate cancer, 1 breast cancer) 25 and the remaining case was an adjuvant radiation delivered after completely resected 1 cutaneous squamous cell carcinoma. Among those 11 patients, 9 had a severe comorbidity or 2 a high frailty score and 10 were later treated with usual fractionation schemes ( Table 1) . 3 Among the 11 patients who had a delayed treatment, 8 had a Rockwood index ≥ 4 and 4 corresponded to a frail or vulnerable profile. Ten patients who had a delay in their radiation 5 treatment received conventional fractionation. That's related to the fact they were related to 6 prostate cancer treated in the postoperative setting where conventional fractionation is mostly 7 used. 8 None of the patients presented any locoregional or distant recurrence when delayed RT was 9 initiated. One patient (patient number 5) was treated with hypofractionation in order to 10 minimize the risk of infection, taking into account her comorbidities and her frailty. Nine 11 (45%) patients were treated during the outbreak using hypofractionated schedules (Figure 1) . The explosion of new cases of Covid-19 within a few weeks after the first case was reported 20 was unexpected. In this context, a complete overhaul of the radiation oncology department 21 was required to protect patients and staff while ensuring the continuity of patient care. 22 Preliminary data showed that patients treated with radiation were at high risk of contracting 23 the virus and were more likely to develop a severe form of the illness because of their 24 underlying immunosuppression related to the cancer and various anticancer drugs (3). According to general radiation guidelines for elderly patients (6,7,8), physicians had to take 1 pragmatic actions in order to mitigate the negative effects of the Covid-19 pandemic in a 2 vulnerable population while ensuring tumor control (8) . Most focused on systemic therapies 3 and selected oncology guidelines, especially from the international early recommendations for 4 departments organization and cancer management during COVID-19 pandemic (10) , that 5 served as a framework for the drafting of a protocol for each tumor location in our 6 department. 7 As radiation oncologists, we had to face several challenges in the management of elderly 8 patients. The main one was related to the risk of under-treatment of the primary tumor versus 9 the risk of infection. A mass screening program would have allowed identification and 10 confinement of non-symptomatic Covid-19 infected patients. Atypical inaugural 11 symptomatology, including fatigue, loss of autonomy, falls, mental confusion and diarrhea, 12 may be associated with respiratory symptoms. There is a necessity to allocate specific slots 13 for consultation, simulation CT, and radiation courses for vulnerable patients which requires 14 additional human and material resources. Implementation of protective measures from 15 caretakers and telemedicine practice and other social distancing measures may increase the 16 feeling of abandonment, isolation and incurability (6, 7). In addition, in our department a 17 specific workflow dedicated to elderly oncologic patients involving a radiation oncologist 18 with oncogeriatric expertise has been implemented prior the pandemic with time slots and a 19 dedicated visits area. This organization was particularly useful in the context of pandemic. 20 Identification of specific problems related to elderly patients was the first step of our 21 treatment approach. The next step was to propose a treatment plan based on evidence-based 22 medicine. In terms of radiotherapy planning, radiation dose, fractionation and techniques had 23 to be optimized and adapted to the emergency context. As recommended by the SIOG (8) and 24 others (10), hypofractioned regimens or shorter schedules might be preferable, avoiding a 1 boost in low risk breast cancer, for example (11). 2 To the best of our knowledge, to date there is no study that has focused on the efficiency of 3 measures taken specifically with radiation therapy for older patients. 4 Our data show that the application of existent cancer and radiation guidelines can be 5 applicable to older patients by taking into account some specificities related to age and 6 individual vulnerability. Sixty percent of our cohort was represented by vulnerable patients 7 with a median age of 78 years. The weekly chart rounds involving a radiation oncologist and 8 physicians specialized in geriatrics allowed us to select patients who were considered eligible 9 for a specific intervention in the treatment schedule by taking into account their frailties. 10 Treatments were delayed in some patients with low risk profile of cancers. The rationale of 11 delaying therapy was to reduce the risk of exposure to Covid 19 patients with low risk of 12 cancer progression. Among those 11 patients who had a delayed treatment, 8 had a Rockwood 13 index ≥ 4 and corresponded to a frail or vulnerable profile. The average length of delay was 2 14 months for breast cancer and 3 months for prostate cancer. Ten patients who had a delay in 15 their radiation treatment received conventional fractionation. Those corresponded to cases of 16 prostate cancer treated in the postoperative setting where conventional fractionation is mostly 17 used. Patients with breast or prostate cancer were offered primary "waiting" hormonal therapy 18 during the outbreak before undergoing radiation. A such approach is well established in 19 prostate cancer (12) . 20 Similarly, hypofractionated radiation consisting of reducing the number of radiation courses 21 was mainly developed for older patients in many cancer types (13, 14) , such as breast, 22 prostate or skin cancer, which represented 95% of our cohort. The modality was particularly 23 adapted for older patients in the context of the pandemic. Multidisciplinary treatment decision was based on international guidelines (9, 10) and on 1 individual comprehensive geriatric assessment during the oncogeriatric visit. We used 2 prospectively a clinical frailty scale according to Rockwood Frailty index which is a 3 multidimensional approach. Unlike Fried frailty index, the Rockwood scale takes into account 4 the social, psychological, the mood, life expectancy, polymedication, functional dependency 5 for activities of daily living and instrumental activities of daily living. 6 Although the decision making for patient management was based on a combination of factors, 7 the Rockwood index was one of the most influential parameter. Patients who had a Rockwood 8 score < 4 typically received upfront radiation whereas those who had a delayed treatment 9 whereas those who had ≥ 4 had a delayed treatment. The rationale of delaying therapy was to 10 reduce the risk of exposure to Covid 19 patients with low risk of cancer progression. 11 Our strategy allowed our patients aged > 75 years to be spared from Covid-19 infection, but 12 oncology outcomes of our cohort is yet to be reported. 13 Since the vast majority of institutions do not have radiation oncologist specialized in 14 oncogeriatrics. a multi-institutional study was not feasible. 15 The optimal management of older patients is often challenging in radiation oncology and 18 requires geriatrics expertise. In our department, a specific workflow dedicated to elderly 19 patients involving one radiation oncologist with oncogeriatrics expertise is used in daily 20 practice. This has been proven particularly useful during the pandemic as the Covid-19 21 outbreak can make the treatment decision even more complicated. Coronavirus-Infected Pneumonia Clinical feature of COVID-19 in elderly patients. A 4 comparaison with young and middle-age patients Cancer patients in SARS-CoV-2 infection: A nationwide 6 analysis in China The official French guidelines to protect patients with 8 cancer against SARS-CoV-2 infection Challenges managing older patients with cancer during 10 Covid-19 pandemic Older cancer patients during the COVID-19 Epidemic: practice proposal of the International Geriatric Radiotherapy Group Community-based treatment of late life 15 depression an expert panel-informed literature review Adapting care for older cancer patients during 18 the COVID-19 pandemic: recommendations from the International Society of Geriatric 19 Oncology (SIOG) COVID-19Working Group Radiation Therapy Department 22 Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to 23 Recommendations for Departments Organization and Cancer Management Priorities during 2 the Global COVID-19 Pandemic. Applicability in Low-and Middle-Income Countries International guidelines on radiation therapy for breast 5 cancer during the COVID-19 pandemic Management of geriatric cancer patients during the COVID-19 pandemic Prostate cancer radiotherapy recommendations 10 in response to COVID-19 COVID-19 Global Radiation Oncology's 13 Targeted Response for Pandemic Preparedness Personalized treatment plan and schedules (7).Masks and Social distancing in waiting rooms (7).Telemedicine for long-term follow up patients (7).Care takers safety (staff rotation, masks) Reduced mobility Adapted (simplified) treatment technique (19)